Loading company…
Luxembourg pharmaceutical company supplying essential emergency medicines, antidotes and rare-disease treatments.
SERB S.a.r.l., known as SERB Pharmaceuticals, supplies essential medicines for complex and life-threatening conditions, including emergency medications, antidotes and treatments for rare diseases, through more than 70 registered products. Founded in 2013 and based in Luxembourg, the company reported USD 82.69 mn revenue and USD 31.89 mn EBITDA for fiscal 2022. Esas invested in June 2023 to support a buy-and-build strategy.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in